Citation 130886

PROTAIS,P: ARBAOUI,J: BAKKALI,EH: BERMEJO,A: CORTES,D:. (1995). EFFECTS OF VARIOUS ISOQUINOLINE ALKALOIDS ON IN VITRO 3H-DOPAMINE UPTAKE BY RAT STRIATAL SYNAPTOSOMES.. 58(10)

Citation Details

Title	EFFECTS OF VARIOUS ISOQUINOLINE ALKALOIDS ON IN VITRO 3H-DOPAMINE UPTAKE BY RAT STRIATAL SYNAPTOSOMES.
Authors	PROTAIS,P: ARBAOUI,J: BAKKALI,EH: BERMEJO,A: CORTES,D:
Year	1995
Volume	58
Issue	10

Summary

Year: 1995

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ANONAINE	ACTIVE
2	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CULARIDINE,SECO:	ACTIVE
3	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STEPHALAGINE,NOR:	ACTIVE
4	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ISOPILINE	ACTIVE
5	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ANOLOBINE	ACTIVE
6	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BOLDINE,ISO:	ACTIVE
7	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MELOSMINE	WEAK ACTIVITY
8	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LIRIODENINE	WEAK ACTIVITY
9	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PUTERINE,N-METHYL:	WEAK ACTIVITY
10	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ISOPILINE,N-METHYL:	WEAK ACTIVITY
11	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BELEMINE,O-METHYL:	WEAK ACTIVITY
12	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BELEMINE	WEAK ACTIVITY
13	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SUAVEOLINE	INACTIVE
14	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LYSICAMINE	INACTIVE
15	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HETEROPSINE	INACTIVE
16	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CULARINE,SECO:	WEAK ACTIVITY
17	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CULARIDEINE	WEAK ACTIVITY
18	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BREOGANINE	WEAK ACTIVITY
19	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SARCOCAPNIDINE	INACTIVE
20	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CLAVICULINE	INACTIVE
21	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CELTISINE	INACTIVE
22	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CULARINE,OXO:	INACTIVE
23	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SARCOPHYLLINE,OXO:	INACTIVE
24	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COCLAURINE	ACTIVE
25	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CRASSIFOLINE,ISO:	WEAK ACTIVITY
26	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARMEPAVINE,NOR:	WEAK ACTIVITY
27	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GRISABINE,DIMETHYL:	ACTIVE
28	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIOQUINE	ACTIVE
29	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OBABERINE	ACTIVE
30	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TETRANDRINE,ISO:	ACTIVE
31	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAURICINE,O-METHYL:	ACTIVE
32	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AROMOLINE,HOMO:	ACTIVE
33	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANDRINE,PSEUDO: DIMETHYL:	ACTIVE
34	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PAMPULHAMINE	WEAK ACTIVITY
35	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUCIDINE,SECO:	INACTIVE
36	DOPAMINE UPTAKE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SECANTHIOQUINE	INACTIVE

Citation 130886

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1